Clinical Trials Directory

Trials / Completed

CompletedNCT03930563

Inorganic Nitrate and OSA

Acute Beetroot Juice Supplementation and Peripheral Chemoreflex Sensitivity in Patients With Obstructive Sleep Apnea

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
University of Iowa · Academic / Other
Sex
All
Age
30 Years – 70 Years
Healthy volunteers
Accepted

Summary

The main purpose of this study is to determine if acute beetroot juice supplementation reduces peripheral chemoreflex sensitivity in patients with obstructive sleep apnea. All subjects will consume low-dose (BRL), higher-dose (BRH), and placebo (BRP) beetroot juice randomly on three independent study visits. Beetroot juice also improves blood flow thus, the investigators will also measure blood flow to the carotid chemoreceptors.

Detailed description

Four-weeks of daily beetroot juice supplementation reduces peripheral chemoreflex sensitivity in healthy older adults who have 'normal' responses to acute hypoxia. Patients with obstructive sleep apnea have exaggerated peripheral chemoreflex sensitivity. It remains unknown if beetroot juice supplementation reduces peripheral chemoreflex sensitivity in patients with obstructive sleep apnea. Additionally, increasing blood flow to the peripheral chemoreceptors reduces sensitivity. Given that beetroot juice improves blood flow, the investigators will also measure common carotid artery blood flow at rest and during hypoxia.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPre-beetroot juice supplementationBefore administering beetroot juice to subjects.
DIETARY_SUPPLEMENTPost-beetroot juice supplementationAfter administering beetroot juice to subjects.

Timeline

Start date
2019-06-12
Primary completion
2020-03-06
Completion
2020-03-06
First posted
2019-04-29
Last updated
2021-04-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03930563. Inclusion in this directory is not an endorsement.